| 查看: 1189 | 回复: 17 | |||
| 当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖 | |||
[交流]
知名医药公司招Project Director
|
|||
|
PROJECT DIRECTOR, INTEGRATED SERVICES & IND ENABLING Qualifications: PhD or equivalence in biomedical science with at least 10 years experience in pharmaceutical industry or contract research organization in project management. Experience in managing drug development projects with proven experience of working effectively in multi- discipline teams; Demonstrated successful leadership, planning and organizational skills with strong knowledge in pharmaceutical R&D from discovery to clinical development and regulatory registration; Familiarity with relevant FDA, SFDA, ICH and EMA/OECD guidelines/regulation and track record on strategic planning and execution of IND/CTA programs in preparation and submission; Experiences in certain functional areas such as DMPK, CMC, Toxicology and/or Pharmacology is a plus; Excellent written and oral communication skills. Responsibilities: The Project Director is responsible for all aspects of a specific cross BU integrated project or IND/CTA-enabling program conducting at WuxiAppTec. This includes but not limited to Integrated Project Strategy Planning and Options Development; Optimizing Operational Efficiency; Project Risk Analysis and Management; Communication Management; and oversee quality control throughout the project life cycle. This position requires direct communications with Sponsors and ability to work across functional units internally to plan, execute, and complete testing programs within scope and required quality according to sponsor s requirements and planned timeline; He/she will define and manage project resource needs and establish project development plans and responsible for monitoring team performance and facilitate adjustments when necessary to ensure goal attainment. He/she will initiate issue-oriented agendas to facilitate effective team meeting discussion and be able to summarize and provide guidance on follow-up strategies to ensure timely resolution of outstanding items. He/She will contribute to proposal strategy, development, costing, and bid defense for assigned business development opportunities and be able to proactively identify out of scope activities, and manage client expectations & serve as key client contact for assigned projects. WuXi AppTec welcomes overseas talents join us. We offer you a highly competitive compensation and full benefits package along with an exciting world-class work environment. For more information, please visit our website: http://www.wuxiapptec.com/ . WuXi AppTec Co., Ltd. is a NYSE listed public company based in Shanghai, China. We offer global pharmaceutical/biopharmaceutical companies diverse outsourcing services in combinatorial, medicinal, synthetic chemistry and manufacturing of API s and finished drug products for preclinical and clinical trials. Our clients include over 80 leading global pharmaceutical and biotech companies in the U.S., Europe and Japan. |
» 猜你喜欢
287求调剂
已经有7人回复
325求调剂
已经有5人回复
343求调剂
已经有4人回复
求调剂推荐 材料 304
已经有4人回复
316求调剂
已经有4人回复
351求调剂
已经有4人回复
349求调剂
已经有5人回复
材料学硕333求调剂
已经有7人回复
342求调剂
已经有3人回复
调剂求收留
已经有7人回复
» 本主题相关商家推荐: (我也要在这里推广)
» 抢金币啦!回帖就可以得到:
基金祈福
+3/1688
山东建筑大学材料类研究生招生调剂
+3/215
电力全国重点实验室双一流A类长江学者团队招2026年全日制博士1名(4月3日截止)
+2/78
浙江大学侯阳教授团队诚聘博士后---高性能固态电解质与固态电池器件设计
+1/76
[b]【材料表征】成分含量丨微观形貌丨分子结构丨材料加工丨预存服务[/b]
+1/72
艾里卡特 (Alicat) - 燃料电池测试系统与质量流量和压力仪表
+3/58
【硕士调剂1名】中国林业科学研究院
+1/47
中原食品实验室 & 郑州轻工业大学2026年硕士研究生联合培养调剂公告
+1/41
福建农林大学材料院招收调剂硕士生
+1/40
沈阳农业大学生物与医药专硕招收调剂生!!!!!!!!!!
+1/37
港科大(广州)招收光学传感器,集成电路设计,医学影像设备以及可穿戴设备方向的博士
+1/9
宁波东方理工大学余鹏课题组2026年上海交大联培博士生、博士后、科研助理招聘
+1/6
Top-88悉尼科技大学数据科学/AI 招收2027年入学 校奖 博士生1到2名(国际和本地学生)
+1/5
武汉纺织大学招收硕士研究生调剂 (社牛最好)
+1/5
上海交大招收26年级秋季入学博士生,CET-6过,生物医用材料方向(有高分子合成基础)
+1/4
Top-88悉尼科技大学数据科学/AI 招收2027年入学 校奖 博士生1到2名(国际和本地学生)
+1/2
福建师范大学环境与资源学院招收2026级硕士生
+1/1
福建师范大学环境与资源学院招收2026级硕士生
+1/1
天津大学浙江研究院(宁波)诚聘高分子/化学/材料/石化方向博士后
+1/1
【博士招生】天津理工大学国家杰青王铁课题组招收2026年博士研究生
+1/1
16楼2012-09-28 19:21:13
2楼2012-09-28 15:43:38
13楼2012-09-28 16:53:05
简单回复
likai113911楼
2012-09-28 16:30
回复
小鱼海角(金币+1): 谢谢参与
















回复此楼